Hope for Alzheimer's psychosis: new drug enters final testing phase
NCT ID NCT06947941
First seen Apr 22, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study tests whether a new combination drug, KarXT + KarX-EC, can safely reduce hallucinations and delusions in people with Alzheimer's disease. About 325 adults aged 55 to 90 with Alzheimer's and psychosis will receive either the drug or a placebo. The goal is to see if the drug eases these distressing symptoms without aiming to cure Alzheimer's itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Inland Psychiatric Medical Group.
RECRUITINGChino, California, 91710, United States
Contact Phone: •••-•••-••••
-
Local Institution - 0001
WITHDRAWNNaples, Florida, 34105, United States
-
Local Institution - 0004
NOT_YET_RECRUITINGMotherwell, ML1 4UF, United Kingdom
Contact
-
Local Institution - 0005
NOT_YET_RECRUITINGExeter, Devon, EX12LU, United Kingdom
Contact
-
Local Institution - 0009
NOT_YET_RECRUITINGChertsey, Surrey, KT160PZ, United Kingdom
Contact
-
Local Institution - 0015
NOT_YET_RECRUITINGOxford, Oxfordshire, OX3 7JX, United Kingdom
Contact
-
Local Institution - 0017
NOT_YET_RECRUITINGSheffield, Yorkshire and the Humber, S47QQ, United Kingdom
Contact
-
Local Institution - 0018
NOT_YET_RECRUITINGSaint Leonards-on-Sea, East Sussex, TN61HB, United Kingdom
Contact
-
Local Institution - 0020
NOT_YET_RECRUITINGMacquarie Park, New South Wales, 2113, Australia
Contact
-
Local Institution - 0023
NOT_YET_RECRUITINGLondon, England, W1G 8TA, United Kingdom
Contact
-
Local Institution - 0024
NOT_YET_RECRUITINGLondon, WC1N3BG, United Kingdom
Contact
-
Local Institution - 0025
NOT_YET_RECRUITINGMontreal, Quebec, H4H 1R3, Canada
Contact
-
Local Institution - 0027
NOT_YET_RECRUITINGWhitby, Ontario, L1N 5S9, Canada
Contact
-
Local Institution - 0029
NOT_YET_RECRUITINGCleveland, Ohio, 44195, United States
Contact
-
Local Institution - 0034
NOT_YET_RECRUITINGOsaka, 550-0006, Japan
Contact
-
Local Institution - 0035
NOT_YET_RECRUITINGNankoku-shi, 783-8505, Japan
Contact
-
Local Institution - 0040
NOT_YET_RECRUITINGSuita, Osaka, 565-0871, Japan
Contact
-
Local Institution - 0042
NOT_YET_RECRUITINGGilbert, Arizona, 85297, United States
Contact
-
Local Institution - 0043
NOT_YET_RECRUITINGShaker Heights, Ohio, 44122-5288, United States
Contact
-
Local Institution - 0052
NOT_YET_RECRUITINGNedlands, Western Australia, 6009, Australia
Contact
-
Local Institution - 0054
NOT_YET_RECRUITINGToronto, Ontario, M6J1H4, Canada
Contact
-
Local Institution - 1401
NOT_YET_RECRUITINGNaples, Florida, 34105, United States
Contact
Conditions
Explore the condition pages connected to this study.